Achieve Life Sciences, Inc. (ACHV) bonds
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.50MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Achieve Life Sciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Achieve Life Sciences's 10-Q for the period ended Dec 31, 2025
Achieve Life Sciences's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Expires |
|---|---|---|
| Contingent Convertible Debt Agreement | $5.00M | Jun 1, 2028 |
| Convertible Debt Agreement | $5.00M | – |
See a number that looks wrong?